Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Institute of Cancer Research, United Kingdom)"
Count: 156
Selected: 0
| NCT ID | Title |
|---|
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation. | ||
| NCT01737255 | Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome | ||
| NCT02753569 | Imaging NSCLC Treatment Response to Immunotherapy | ||
| NCT02541266 | Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation | ||
| NCT02403102 | Imageguided Theranostics in Multiple Myeloma | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT02305654 | International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT01685190 | A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer | ||
| NCT00814567 | Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT03479151 | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT01726374 | Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT | ||
| NCT03934164 | Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO | ||
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | ||
| NCT01505829 | Diffusion-weighted Imaging Study in Cancer of the Ovary | ||
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT03327662 | Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer | ||
| NCT02955082 | The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment | ||
| NCT05990192 | SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy | ||
| NCT05968417 | Myeloma Novel Drug Discovery Ver 1.2 | ||
| NCT05810467 | The Active Surveillance Study | ||
| NCT05782361 | POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC | ||
| NCT04763317 | Precision Medicine in the Prostate Cancer Care Pathway | ||
| NCT04686188 | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer | ||
| NCT04659252 | CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19) | ||
| NCT04595019 | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer | ||
| NCT04584853 | PreOperative Endocrine Therapy for Individualised Care With Abemaciclib | ||
| NCT04458311 | Abiraterone Acetate in Combination With Tildrakizumab | ||
| NCT04007861 | Exploring the Link Between Cancer Genetics and PPSP | ||
| NCT03946202 | KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer | ||
| NCT03875820 | Phase I Trial of Defactinib and VS-6766. | ||
| NCT03857477 | The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. | ||
| NCT03809377 | Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2) | ||
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer |
